Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma
- PMID: 16712906
- DOI: 10.1016/j.ygyno.2006.03.047
Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma
Comment on
-
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.Gynecol Oncol. 2006 Jun;101(3):464-9. doi: 10.1016/j.ygyno.2005.11.010. Epub 2005 Dec 20. Gynecol Oncol. 2006. PMID: 16368128
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
